Lexington Biosciences, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced net loss was CAD 45,210 compared to CAD 101,025 a year ago. Basic eps - continuing operations was CAD 0 compared to CAD 0.03 a year ago. For the nine months, net loss was CAD 389,801 compared to CAD 431,350 a year ago. Basic earnings per share from continuing operations was CAD 0.06 compared to CAD 0.11 a year ago.